Intramuscular Paliperidone Palmitate

Author： Hoy Sheridan M. Scott Lesley J. Keating Gillian M.

ISSN： 1172-7047

Source： CNS Drugs, Vol.24, Iss.3, 2010-03, pp. : 227-244

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intramuscular prolonged-release paliperidone palmitate: a guide to its use in schizophrenia

Drugs & Therapy Perspectives, Vol. 27, Iss. 11, 2011-11 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Extended-Release Intramuscular Paliperidone Palmitate: A Review of its Use in the Treatment of Schizophrenia

By Carter Natalie J.

Drugs, Vol. 72, Iss. 8, 2012-05 ,pp. : 1137-1160

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics of Intramuscular Paliperidone Palmitate in Patients with Schizophrenia: A Novel Once-Monthly, Long-Acting Formulation of an Atypical Antipsychotic

By Samtani Mahesh N.

Clinical Pharmacokinetics, Vol. 48, Iss. 9, 2009-09 ,pp. : 585-600

Adis International

Access to resources Recommend Favorite

Pharmacokinetic profile after multiple deltoid or gluteal intramuscular injections of paliperidone palmitate in patients with schizophrenia

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 4, 2015-07 ,pp. : 270-278

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dosing and Switching Strategies for Paliperidone Palmitate: Based on Population Pharmacokinetic Modelling and Clinical Trial Data

By Samtani Mahesh N.

CNS Drugs, Vol. 25, Iss. 10, 2011-10 ,pp. : 829-845

Adis International

Access to resources Recommend Favorite